(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | ---- | -8.25%14.36B | ---- | ---- | ---- | -1.41%15.65B | ---- | -27.28%29.34B | ---- | -17.60%15.88B |
Special items of operating revenue | -3.57%20.94B | ---- | -3.34%6.78B | ---- | -2.96%21.71B | ---- | 14.02%7.01B | ---- | -22.35%22.38B | ---- |
Operating income | -3.57%20.94B | -8.25%14.36B | -3.34%6.78B | -32.43%19.82B | -2.96%21.71B | -1.41%15.65B | 14.02%7.01B | -27.28%29.34B | -22.35%22.38B | -17.60%15.88B |
Operating expenses | ||||||||||
Gross profit | ||||||||||
Administrative expenses | -4.99%-6.75B | ---- | 2.47%-2.04B | ---- | 1.76%-6.43B | ---- | -27.36%-2.09B | ---- | 21.75%-6.55B | ---- |
Employee expense | ---- | 3.48%-3.11B | ---- | ---- | ---- | -6.63%-3.23B | ---- | 30.22%-5.8B | ---- | 32.18%-3.03B |
Depreciation and amortization | ---- | -12.22%-422.28M | ---- | ---- | ---- | -10.47%-376.28M | ---- | -8.04%-697.54M | ---- | -7.98%-340.63M |
Impairment and provision | 176.08%112.38M | 74.37%-37.69M | 25.26%45.33M | ---- | 62.19%-147.7M | 30.77%-147.07M | 127.93%36.19M | 18.31%-307.46M | -31.08%-390.61M | -41.65%-212.44M |
-Other impairment is provision | 176.08%112.38M | 74.37%-37.69M | 25.26%45.33M | ---- | 62.19%-147.7M | 30.77%-147.07M | 127.93%36.19M | 18.31%-307.46M | -31.08%-390.61M | -41.65%-212.44M |
Operating interest expense | 2.69%-6.66B | -1.67%-4.56B | -10.00%-2.48B | ---- | 3.34%-6.84B | 7.24%-4.49B | 8.15%-2.25B | ---- | -0.62%-7.08B | -8.36%-4.84B |
Special items of operating profit | 99.90%-1.26M | 32.98%-1.96B | ---- | ---- | 4.66%-1.3B | 16.29%-2.92B | 55.50%-125.76M | 30.28%-6.33B | 51.36%-1.36B | 6.73%-3.49B |
Operating profit | 9.45%7.56B | -5.04%4.22B | -10.74%2.27B | -42.59%9.3B | 0.15%6.91B | 13.90%4.44B | 59.20%2.55B | 33.82%16.2B | -32.30%6.9B | -35.67%3.9B |
Financing cost | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---9.33B | ---- | ---- |
Share of profits of associates | ---- | -2.38%751.39M | ---- | ---- | ---- | -10.14%769.71M | ---- | 3.84%1.66B | ---- | 13.82%856.52M |
Special items of earning before tax | -397.74%-4.09M | ---- | -238.20%-2.94M | ---- | 101.62%1.37M | ---- | 126.60%2.13M | ---- | -250.90%-84.62M | ---- |
Earning before tax | 9.37%7.56B | -4.64%4.97B | -10.93%2.27B | 8.96%9.3B | 1.41%6.91B | 9.57%5.21B | 60.13%2.55B | -37.74%8.53B | -32.97%6.82B | -30.20%4.76B |
Tax | 19.67%-407.59M | 54.57%-218.32M | 60.91%-113.22M | ---- | 3.49%-507.39M | -5.28%-480.61M | -200.31%-289.65M | 77.78%-454.53M | 68.27%-525.76M | 56.97%-456.52M |
After-tax profit from continuing operations | 11.67%7.15B | 0.43%4.75B | -4.53%2.16B | 1.82%6.41B | 10.03%4.73B | 51.10%2.26B | -30.71%8.08B | -26.09%6.29B | -25.27%4.3B | |
Earning after tax | 11.67%7.15B | 0.43%4.75B | -4.53%2.16B | 1.82%6.41B | 10.03%4.73B | 51.10%2.26B | -30.71%8.08B | -26.09%6.29B | -25.27%4.3B | |
Minority profit | -19.97%3.06M | -13.37%2.27M | 24.17%1.07M | ---- | -55.01%3.82M | -62.03%2.62M | -81.32%858.82K | -45.95%6.89M | -20.80%8.49M | 3.65%6.89M |
Profit attributable to shareholders | 11.68%7.15B | 0.44%4.75B | -4.54%2.16B | 8.60%8.76B | 1.90%6.4B | 10.14%4.73B | 51.50%2.26B | -30.70%8.07B | -26.10%6.28B | -25.30%4.29B |
Basic earnings per share | 11.59%0.77 | 0.00%0.51 | -4.17%0.23 | 9.30%0.94 | 2.99%0.69 | 10.87%0.51 | 60.00%0.24 | -31.20%0.86 | -26.37%0.67 | -24.59%0.46 |
Diluted earnings per share | 11.59%0.77 | 0.00%0.51 | -4.17%0.23 | 2.99%0.69 | 10.87%0.51 | 60.00%0.24 | -31.20%0.86 | -26.37%0.67 | -24.59%0.46 | |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | IAS | CAS (2007) | CAS (2007) | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data